Advocacy

Genetics research is providing remarkable insights into the human genome and how this knowledge can be translated into healthcare advances. This scientific progress relies on continued public investment in biomedical research. ASHG supports the robust, predictable, sustainable federal funding of research to fuel scientific advances. Related: Written Testimony to Congress for FY 2024 (March 2023)... Read More

A new report commissioned by ASHG examines how human genetics and genomics is growing the U.S. economy and becoming increasingly integrated in healthcare and society. The new report, titled “The Economic Impact and Functional Applications of Human Genetics and Genomics,” indicates that the human genetics and genomics sector contributes $265 billion to the U.S. economy... Read More

*Editors Note: Data provided in an early version of the press release was incorrect related to the number of people worldwide being treated for rare diseases. These conditions affect 25-30 million people in the U.S. and 350 million worldwide. Published: May 19, 2021, 8:00 a.m. U.S. Eastern Time Media Contact: Kara Flynn, 202.257.8424, press@ashg.org   Economic Analysis Shows... Read More

Dear ASHG Members, Today ASHG is releasing a new report on how human genetics and genomics is growing the U.S. economy and becoming increasingly integrated in healthcare and society. The new report, titled “The Economic Impact and Functional Applications of Human Genetics and Genomics,” indicates that the human genetics and genomics sector contributes $265 billion... Read More

Posted By: Lyly Luhachack, PhD, Policy & Advocacy Specialist, ASHG April 22, 2021, marked the first-ever ASHG Capitol Hill Day. The Government and Public Advocacy Committee (GPAC), ASHG President Gail Jarvik, MD, PhD, Dana Crawford, PhD, Diversity, Equity, and Inclusion Task Force (DEITF) Chair, and leaders of the Career Development Committee (CDC) met, virtually, with... Read More